These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4136988)

  • 1. Letter: Relief of action myoclonus by 5-hydroxytryptophan.
    Chadwick D; Reynolds EH; Marsden CD
    Lancet; 1974 Jul; 2(7872):111-2. PubMed ID: 4136988
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: Treatment of post-anoxic intention myoclonus.
    Van Woert MH; Sethy VH
    Lancet; 1974 Jun; 1(7869):1285. PubMed ID: 4134164
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: L 5-Hydroxytryptophan and mood.
    Trimble M; Chadwick D; Reynolds EH; Marsden CD
    Lancet; 1975 Mar; 1(7906):583. PubMed ID: 47066
    [No Abstract]   [Full Text] [Related]  

  • 4. Improvement of action myoclonus by an administration of 5-hydroxytryptophan and carbidopa in a child with muscular subsarcolemmal hyperactivity.
    Nakano K; Hayakawa T; Shishikura K; Ohsawa M; Suzuki H; Fukuyama Y
    Brain Dev; 1990; 12(5):516-20. PubMed ID: 2288384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Utilization of levo-5-hydroxytryptophan in post-anoxic myoclonus].
    Rascol A; Guiraud-Chaumeil B; Laboucarie J; Montastruc JL; El-Hage W
    Therapie; 1978; 33(5):623-8. PubMed ID: 311085
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term therapy of myoclonus and other neurologic disorders with L-5-hydroxytryptophan and carbidopa.
    Van Woert MH; Rosenbaum D; Howieson J; Bowers MB
    N Engl J Med; 1977 Jan; 296(2):70-5. PubMed ID: 401457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of cherry red spot-myoclonus syndrome with 5-hydroxytryptophan.
    Gascon G; Wallenberg B; Daif AK; Ozand P
    Ann Neurol; 1988 Sep; 24(3):453-5. PubMed ID: 3265864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Letter: Relief of myoclonus by L-tryptophan.
    DeLéan J; Richardson JC
    Lancet; 1975 Nov; 2(7940):870-1. PubMed ID: 53353
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapy of intention myoclonus with L-5-hydroxytryptophan and a peripheral decarboxylase inhibitor, MK 486.
    Van Woert MH; Sethy VH
    Neurology; 1975 Feb; 25(2):135-40. PubMed ID: 1078720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin and myoclonic seizures.
    Munsat TL
    N Engl J Med; 1977 Jan; 296(2):101-2. PubMed ID: 299730
    [No Abstract]   [Full Text] [Related]  

  • 11. Post-hypoxic intention myoclonus treated with 5-hydroxy-tryptophan and an extracerebral decarboxylase inhibitor.
    Magnussen I; Dupont E; Engbaek F; de Fine Olivarius B
    Acta Neurol Scand; 1978 Apr; 57(4):289-94. PubMed ID: 307327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Hydroxytryptophan-induced myoclonus in guinea pigs and the possible role of serotonin in infantile myoclonus.
    Klawans HL; Goetz C; Weiner WJ
    Neurology; 1973 Nov; 23(11):1234-40. PubMed ID: 4147723
    [No Abstract]   [Full Text] [Related]  

  • 13. [Letter: Combination of a dopa decarboxylase inhibitor with 5-hydroxytryptophan therapy].
    Lhermitte F; Degos CF; Marteau R
    Nouv Presse Med; 1975 Jan; 4(1):31. PubMed ID: 1079935
    [No Abstract]   [Full Text] [Related]  

  • 14. Posttraumatic intention myoclonus.
    Starosta-Rubinstein S; Bjork RJ; Snyder BD; Tulloch JW
    Surg Neurol; 1983 Aug; 20(2):131-2. PubMed ID: 6603671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postanoxic myoclonus. Treatment of a case with 5-hydroxytryptophane and a decarboxylase inhibitor.
    Beretta E; Regli F; de Crousaz G; Steck AJ
    J Neurol; 1981; 225(1):57-62. PubMed ID: 6164757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional independence in post-anoxic myoclonus: contribution of L-5-HTP sodium valproate and clonazepam.
    Carroll WM; Walsh PJ
    Br Med J; 1978 Dec; 2(6152):1612. PubMed ID: 365292
    [No Abstract]   [Full Text] [Related]  

  • 17. Manipulation of brain serotonin in the treatment of myoclonus.
    Chadwick D; Jenner P; Harris R; Reynolds EH; Marsden CD
    Lancet; 1975 Sep; 2(7932):434-5. PubMed ID: 51240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Case of intention myoclonus (Lance-Adams syndrome) and a dramatic effect of L-5-hydroxytryptophan].
    Satoyoshi E; Kinoshita M; Takazawa Y; Yoda K
    Rinsho Shinkeigaku; 1976 Sep; 16(9):654-60. PubMed ID: 1087598
    [No Abstract]   [Full Text] [Related]  

  • 19. Beneficial effects of serotonin precursors in postanoxic action myoclonus.
    De Léan J; Richardson JC; Hornykiewicz O
    Neurology; 1976 Sep; 26(9):863-8. PubMed ID: 1084968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical challenge of posthypoxic myoclonus.
    Frucht SJ
    Adv Neurol; 2002; 89():85-8. PubMed ID: 11968475
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.